Analyst Ratings for MapLight Therapeutics (MPLT)
MPLT Rating Summary
MPLT Price Target Summary
- Highest: $34.00 (Morgan Stanley)
- Lowest: $28.00 (Stifel)
- Average: $31.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$31.00 (+67.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$31.00 (+67.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/21/2025 | Leerink Partners | Marc Goodman | New Coverage | Outperform (N/A) |
30.00 (N/A) |
13.29 (18.51) |
39.28% | Details |
| 11/21/2025 | Jefferies » Updated 12/3/2025 |
Andrew Tsai | New Coverage | Buy (N/A) |
32.00 (N/A) |
14.60 (18.51) |
26.78% | Details |
 |
||||||||
|
||||||||
